https://scholars.lib.ntu.edu.tw/handle/123456789/496159
標題: | Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan | 作者: | CHIN-HSIAO TSENG | 公開日期: | 2009 | 卷: | 42 | 期: | 44115 | 起(迄)頁: | 1019-1024 | 來源出版物: | Clinical Biochemistry | 摘要: | Background: This study evaluated the lipid abnormalities associated with different stages of albuminuria in type 2 diabetic patients. Methods and results: A total of 549 patients (245 men and 304 women) with mean age of 63.4 were studied. Normoalbuminuria (n = 251), microalbuminuria (n = 242) and macroalbuminuria (n = 56) were defined as albumin-to-creatinine ratio of < 30, 30-299 and ? 300?μg/mg, respectively. Lipid parameters included total cholesterol, triglyceride (TG), high- and low-density lipoprotein (LDL) cholesterol, apolipoproteins A1 and B (ApoB), and lipoprotein(a) [Lp(a)]. Results showed that ApoB differed significantly (p < 0.05) between normoalbuminuria and microalbuminuria/macroalbuminuria and Ln[Lp(a)] differed between normoalbuminuria/microalbuminuria and macroalbuminuria. Ln(TG) increased progressively with increasing albuminuria. In multivariate logistic regression analyses, only ApoB showed significant odds ratio (95% confidence interval) for microalbuminuria: 1.013 (1.004-1.022); and both ln(TG) and ln[Lp(a)] were significant for macroalbuminuria [respective odds ratios: 1.995 (1.010-3.938) and 1.708 (1.200-2.430)]. Conclusions: A differential dyslipidemia is observed for microalbuminuria and macroalbuminuria. Apo(B) and Lp(a) increase at the stages of microalbuminuria and macroalbuminuria, respectively. However, TG increases significantly throughout the three stages of albuminuria. ? 2009 The Canadian Society of Clinical Chemists. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-67349275026&doi=10.1016%2fj.clinbiochem.2009.03.013&partnerID=40&md5=5216e30c77cdb9026f59060664649725 https://scholars.lib.ntu.edu.tw/handle/123456789/496159 |
ISSN: | 0009-9120 | DOI: | 10.1016/j.clinbiochem.2009.03.013 | SDG/關鍵字: | angiotensin receptor antagonist; apolipoprotein A1; apolipoprotein B; cholesterol; dipeptidyl carboxypeptidase inhibitor; fibric acid derivative; high density lipoprotein cholesterol; hydroxymethylglutaryl coenzyme A reductase inhibitor; insulin; lipoprotein; low density lipoprotein cholesterol; oral antidiabetic agent; triacylglycerol; adult; albumin blood level; albuminuria; article; cholesterol blood level; cohort analysis; controlled study; creatinine blood level; creatinine urine level; cross-sectional study; diabetic nephropathy; disease association; disease severity; dyslipidemia; female; follow up; human; hypertension; longitudinal study; major clinical study; male; microalbuminuria; non insulin dependent diabetes mellitus; priority journal; protein blood level; Taiwan; triacylglycerol blood level; urine level; Albuminuria; Asian Continental Ancestry Group; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Humans; Lipids; Male; Middle Aged; Odds Ratio; Taiwan |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。